EPM
AKCA

Equitec Proprietary Markets’s Akcea Therapeutics Inc AKCA Stock Holding History

Equitec Proprietary Markets’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,500
Closed -$172K – 153
2020
Q3 		$172K Buy
+9,500
New +$135K 0.13% 56

Equitec Proprietary Markets's AKCA Position: Q4 2020 in Review

Equitec Proprietary Markets sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 9,500 shares — an estimated $172K sold.

Equitec Proprietary Markets first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $172K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Equitec Proprietary Markets reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Equitec Proprietary Markets sold 9,500 Akcea Therapeutics Inc shares in Q4 2020, an estimated $172K.
  • Equitec Proprietary Markets first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
  • Equitec Proprietary Markets's Akcea Therapeutics Inc position peaked at $172K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Equitec Proprietary Markets's 13F filing for Q4 2020, filed 26 Jan 2021.